MIPS Home MIPS General Information MIPS Grants MIPS Courses MIPS Research MIPS Software MIPS Web Tools MIPS Sitemap
About MIPS MIPS News Faculty & Staff Recent Pubs Directions Facilities Events & Meetings Employment Associated Depts Useful Links
Grant News CCNE-TR CVIS ICMIC ICBP NTROI SMIS
BIOE222 Pharmacokinetics Stats & Data Analysis
BIOE222A F2009 BIOE222B W2009 BIOE222A F2008 BIOE222B W2008 BIOE222A F2007 BIOE222B W2007 BIOE222 F2006 BIOE222 F2005 BIOE222 F2004
Biswal Lab Blankenberg Lab Cheng Lab Contag Lab Felsher Lab Gambhir Lab Graves Lab Guccione Lab Levin Lab Lin Lab McConnell Moseley Lab Paik Lab Plevritis Lab Ramasamy Lab Rao Lab Rutt Lab Schnitzer Lab Vasanawala Lab Willmann Lab Wu Lab Xing Lab
NCIL MRSRL
AMIDE
NucMed Mediabook PET Brain Atlas PET-FDG Whole Body Atlas




CCNE Home

Nanobiotechnology Seminar

Annual Symposium

CCNE News

Faculty

Postdocs
Graduate Students

Scientific Papers

Corporate Collaboration

Private Foundations

Projects

Core Resources

Pilot Projects

Leadership & Organization

Environment

Links

Employment Opportunities


Center for Cancer Nanotechnology Excellence Focused on Therapy Response

2009 Annual CCNE-TR Symposium

Samir Hanash, M.D., Ph.D.

Samir Hanash, M.D., Ph.D.
Program Head, Molecular Diagnostics Program
Fred Hutchinson Cancer Research Center

Dr. Sam Hanash joined the faculty at the Fred Hutchinson Cancer Research Center as a Full Member in August of 2004. His prior position was as a full professor at the University of Michigan.

Sam was recruited to be the Program Head for a developing program, "Molecular Diagnostics," which will focus on biomarker discovery for the early detection of cancer. Sam Hanash has been a leader in protocol development and execution in the field of proteomics for over over 15 years.

The goal of Dr. Hanash's research program at the Hutchinson Center is to identify trace proteins called "markers" that are secreted into the blood by tumors, or present in cells or tissues, and could be used for early detection and diagnosis of lung, liver, pancreatic and other cancers. Molecular Diagnostics is a multi-disciplinary program that utilizes proteomics, genomics, and bioinformatics. This combination of approaches is expected to lead to highly sensitive early cancer-detection tests, a major goal of the Fred Hutch's Early Detection Initiative.

[ Back ]
crumpnews events